This drug is indicated in ulcerative colitis, rheumatoid arthritis, and ankylosing spondylitis.

Mild to moderate side the effect has been observed such as high blood pressure, respiratory tract infection, and an increase in liver enzyme

This drug is to be cautiously used in patients with a blood disorder, an autoimmune disorder, heart problem, pregnancy, and lactation.

This drug is contraindicated in patients with severe infection and hypersensitivity.

For rheumatoid arthritis, ankylosing spondylitis in adults usual dose consists of 50 mg injection to be administered subcutaneously once in a month. For ulcerative colitis- In adult usual dose consists of a 200 mg injection to be administered subcutaneously.

We have also established roots and begun this new venture in other countries as well such as Srilanka, Japan Russia.

Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai